January 11-15th 2021:

Defymed is happy to participate to the Biotech showcase and Bio Partenring at JP Morgan virtual sessions that will be held from Monday 11th January to Friday 15th January.
During this event, Defymed will be part of the French Healthcare corner at JP MORGAN WEEK organized by Business France. This is a unique chance for us to identify and meet with a high number of potential partners in one-to-one meetings, and gain insight from experts and leaders on the most important trends and challenges our industry faces. Richard Bouaoun, Chief Operating Officer will attend the digital conference.

For more info

In parallel, and due to the sanitary crisis, Defymed will also attend the BIO partnering at JP Morgan. The 2021 conference will offer access to partneringONE® to schedule one-to-one meetings with innovative medtech and biotech companies. Manuel Pires, our business developer will be your contact to discuss with Defymed.

For more info

In both events, the objective of Defymed is to explore opportunities to establish new strategic partnerships with international companies. For ExOlin®, our physiologic drug delivery device, the objective is to start collaborations in diverse new applications, such as for cancer therapy or pain management, to improve efficacy of drugs and therefore, patients’ quality of life. For MailPan®, our cell encapsulation device, we are also exploring the impact of cell therapy in hemophilia or pituitary diseases which might solve important unmet medical needs in such chronic diseases.
We are also open for discussions with potential investors to help bringing faster our innovations towards patients.

If you wish to meet us, do not hesitate to contact us at : info@defymed.com or to send us an invitation on one or the two events’ platforms